Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Particle Sciences, now a part of Lubrizol Life Science Health, is a leading contract development and manufacturing organization (CDMO) specializing in complex drug delivery systems. The company provides a comprehensive range of services, including formulation development, analytical testing, and clinical trial manufacturing, with a particular focus on poorly soluble compounds. Their expertise spans various dosage forms, including ophthalmic, topical, injectable, and mucosal delivery systems. By leveraging advanced technologies such as lipid nanoparticles and polymeric microparticles, Particle Sciences helps pharmaceutical and biotech partners accelerate the development of challenging therapeutic candidates. The company operates state-of-the-art facilities that are compliant with global regulatory standards, supporting projects from initial concept through to commercial production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eyeon Particle Sciences.